The data science start-up is now part of the Beta Innovation Fund portfolio, which will continue to invest in the most promising R&D-based technology companies.

Nanotechnology company applied to surface protection is acquired by a company in the sector with an international presence.

This is the first investment of the recently launched EUR 10 million Beta Innovation Fund, aiming to invest in early-stage tech-based start-ups.

ImpactLab Group enters the international market by acquiring 100% of HeartGenetics.